Haploinsufficient SYNGAP1 mice treated with CMP-SYNGAP-01 demonstrated an increase in SYNGAP1 protein levels; treatment rescued multiple SYNGAP1-dependent behavioral phenotypes CMP-SYNGAP-01…
LEUVEN, Belgium, May 16, 2025 (GLOBE NEWSWIRE) — Materialise NV (NASDAQ:MTLS), a leading provider of additive manufacturing software and sophisticated…